www.malvernpanalytical.com Open in urlscan Pro
34.242.48.102  Public Scan

Form analysis
1 forms found in the DOM

GET /en/search

<form class="c-header__search" action="/en/search" method="get">
  <label for="site-search" class="u-hidden">Search</label>
  <div class="u-flex u-bg-petrol-step-3">
    <input id="site-search" placeholder="Search" type="search" name="q" class="c-input c-input--alt c-input--with-button">
    <button type="submit">
      <svg role="img" aria-hidden="true" focusable="false" class="mp c-icon c-icon--search">
        <use xlink:href="/resource/svg/sprite.svg#search"></use>
      </svg>
    </button>
  </div>
</form>

Text Content

 * Language Deutsch English Español Français Português 한국어 日本語 简体中文 繁體中文
 * About us
 * Careers
 * Blog
 * Store
 * Contact us

Search

 * Products
 * Solutions
 * Webinars and events
 * Resources
 * Support & downloads
 * * Login
   * Register

 1. Home
 2. Campaigns


2024 USA PHARMACEUTICAL WEBINAR SERIES


 1. Introduction
 2. LNP webinar series
 3. Characterizing Exosomes and Nanoparticles
 4. Pharmaceutical Development Series
 5. Method Validation Series

Contact sales

We've got a fantastic selection of events coming in 2024 to support your
pharmaceutical journeys!

From LNPs to nanoparticles, from data to processes, we'll be exploring a range
of insightful topics, with an opportunity to ask your specific questions at each
event.

Want to know more? 

Take a look at the summary information below and register for free for any
sessions in our webinar series - and keep an eye out for the recordings
afterwards too!


LNP WEBINAR SERIES

In this three-part webinar series, we will explore several areas critical to LNP
vaccine and gene therapy development.

Topics include an overview of LNP structure and formulation, the common and
advanced analytics used to characterize LNPs, and what LNP physicochemical
properties are measured.

We will discuss in-depth the light scattering analytics used to measure LNP
size, polydispersity, charge, and particle concentration.

Catch up with our LNP Series webinars on demand below.


KEY CONSIDERATIONS FOR CHARACTERIZING LNPS

Watch now
Key Considerations for characterizing LNPs


UNDERSTANDING AND CONTROLLING STABILITY OF LNPS USING DLS AND NTA

Watch now
Understanding and Controlling Stability of LNPs Using DLS and NTA


THE ROLE OF CHARGE IN THE FORMULATION OF LNPS

Watch now
The Role of Charge in the Formulation of LNPs


CHARACTERIZING EXOSOMES AND NANOPARTICLES

In this three-part webinar series, we will explore nanoparticles and NTA.

Biological nanoparticles are being explored for a range of applications within
the life science industry, such as diagnostics and gene delivery. The ability to
characterize these particles is a crucial part of understanding their behavior
and effectiveness. In this three-part webinar series, we will explore several
areas in the characterization of exosomes and other biologically-sourced
nanoparticles, including an overview of techniques commonly used to characterize
biologically sourced nanoparticles, with a special focus on nanoparticle
tracking analysis (NTA). In addition, we will discuss, in-depth, the best
practices to obtain quality NTA data, and how to optimize fluorescence NTA
measurements. 

Find out more about each webinar in this series below:

 * Webinar 1: Utilization and Characterization of Biologically sourced
   Nanoparticles: Exosomes and viral particles
 * Webinar 2: Optimizing Fluorescence for NTA measurements
 * Webinar 3: NTA and Best Practice: How to optimize data quality


UTILIZATION AND CHARACTERIZATION OF BIOLOGICALLY SOURCED NANOPARTICLES: EXOSOMES
AND VIRAL PARTICLES

Watch now
Utilization and Characterization of Biologically Sourced Nanoparticles: Exosomes
and Viral particles


OPTIMIZING FLUORESCENCE FOR NANOPARTICLE TRACKING ANALYSIS MEASUREMENTS

Watch now
Optimizing Fluorescence for Nanoparticle Tracking Analysis Measurements


NTA AND BEST PRACTICE: HOW TO OPTIMIZE DATA QUALITY

Watch now
NTA and Best Practice: How to optimize data quality


LAB TO CLINIC: PHARMACEUTICAL DEVELOPMENT SERIES

The development of successful pharmaceutical drugs is a long time-consuming and
expensive process. Each stage of the development workflow has unique challenges
and requirements, each with its own analytical and characterization needs.

In this 3-part webinar series, we will cover a range of topics within the
pharmaceutical development process starting with candidate selection and
screening for binding kinetics, moving on to screening and controlling for API
polymorphs, and finishing up with the development of nasal sprays, aerosols and
inhalers for drug delivery.

Throughout this series, we will highlight how technical challenges can be
overcome by utilizing the appropriate analytical tools.    

Rapid screening for binding kinetics


RAPID SCREENING FOR BINDING KINETICS

July 11 2024, 1 PM-2 PM EDT | Virtual

Kinetic screening is a crucial aspect of the drug discovery process, from
confirmation of binding in early discovery to fine-tuning of drug-like
properties in pre-clinical development. Register now >>

Screening and Controlling API Polymorphs


SCREENING AND CONTROLLING API POLYMORPHS

July 25 2024, 1 PM - 2 PM EDT | Virtual

Find out how control of polymorphism can impact the safety of drug products, and
how to screen and identify impacts. Register now >>

Developing nasal sprays, aerosols and inhalers for drug delivery


DEVELOPING NASAL SPRAYS, AEROSOLS AND INHALERS FOR DRUG DELIVERY

August 8 2024, 1 PM - 2 PM EDT | Virtual

We outline challenges, analytical testing, and troubleshooting encountered with
OINDP. Register now >>


METHOD VALIDATION SERIES

Within the pharmaceutical industry, development of robust, reliable methods is
crucial to the development of successful pharmaceutical products. This becomes
even more critical in the later stages of the development stages, as regulated
laboratories and environments are required to support CMC filing. 

In this 4 part webinar series, we will introduce some of the latest ICH and ISO
guidelines for select analytical technologies. Then, we will go into specific
details around 3 of our core QC technologies, Laser Diffraction, Light
Scattering and X-Ray Diffraction. This webinar series will be invaluable to
researchers and pharmaceutical development scientists looking to employ these
technologies in regulated laboratories. 

Challenges Associated with Validation in Regulatory Environment


CHALLENGES ASSOCIATED WITH VALIDATION IN REGULATORY ENVIRONMENT

November 14 2024, 1-2 PM EDT | Virtual

This webinar will cover key messages from guidance documents, and provide
practical advice on method and system validation.

Register now >

Effective Method Development and Validation for the Mastersizer 3000


EFFECTIVE METHOD DEVELOPMENT AND VALIDATION FOR THE MASTERSIZER 3000

November 26 2024, 1-2 PM EDT | Virtual

We guide analysts of all skill levels through the process of developing a
particle size distribution method on the MS3000.

Register now >

Key Considerations for Validation


KEY CONSIDERATIONS FOR VALIDATION

December 5 2024, 1-2 PM EDT | Virtual

Intended for existing Zetasizer Advanced users, we provide best practice for
method development for different technologies, and between Zetasizer models.

Register now >

Best Practice for Developing and Validation XRD Methods


BEST PRACTICE FOR DEVELOPING AND VALIDATION XRD METHODS

December 12 2024, 1-2 PM EDT | Virtual

We explore XRD system optical components and how they affect the collected XRD
data, plus how to optimize sample preparation for consistent results.

Register now >



 * POPULAR LINKS
   
   * Near-infrared reflectance spectroscopy
   * Particle size
   * Phase identification
   * Viscosity
     
   * X-ray diffraction (XRD)
   * X-ray fluorescence (XRF)
   * Zeta potential

 * SUPPORT AND SERVICES
   
   * Product support
   * Events and training
   * Knowledge center
   * Software downloads

 * COMPANY PROFILE
   
   * About Malvern Panalytical
   * Careers
   * Brands
   * Awards
   * Meet our experts
   * Code of business ethics
   * Press releases
   * Customer stories
   * Sustainability

 * LEGAL INFORMATION
   
   * Website disclaimer
   * Terms and conditions
   * Cookie notice
   * Third-party privacy notice
   * Trademarks
   * Anti-slavery and trafficking statement

 * 
 * 
 * 
 * 
 * 
 * 

 * Site map
 * Cookie settings

© Copyright 2024 - Malvern Panalytical Ltd is a Spectris company

We use cookies to help the website function, to ensure we give you the best
experience, and to show relevant advertisements tailored to your interests.
Click ‘Accept' to continue using the website or click 'Cookie settings' to
change your cookie preferences.Cookie notice
Accept
Reject
Cookies settings

Feedback